Please login to the form below

Not currently logged in
Email:
Password:

Nigel Brooksby joins Doctors.net.uk

Online professional network adds former Sanofi UK chairman and MD to its advisory board

Former Sanofi UK chairman and managing director Nigel Brooksby has joined the advisory board of online professional network Doctors.net.uk.

Brooksby, who has worked in pharma for nearly 40 years, is also a former president of the Association of the British Pharmaceutical Industry (ABPI) and currently holds several government and academic senior board and chairman roles.

Nigel Brooksby said: “Keeping up-to-date and informed about the many changes and their implications in the current healthcare environment can be a major challenge. I am delighted to be joining the advisory board of Doctors.net.uk and I hope that my contribution will help to maintain its dominant position as the network which provides the most trusted source of information to healthcare professionals.”

Doctors.net.uk said Brooksby would play a pivotal role in helping shape its thinking on current and future healthcare policy trends.

CEO Dr Tim Ringrose said: “We are delighted to welcome Nigel to our advisory board. His extensive knowledge and experience in healthcare policy will inform our thinking in this area as Doctors.net.uk provides innovative digital engagement solutions for industry to reach and engage target groups of doctors.

“Nigel's expertise will also help us to ensure that we continue to provide the best solutions for industry in the healthcare sector to respond to the new environment of drug development, market access and marketing.”

14th February 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Page & Page and Partners

For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...

Latest intelligence

Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...
Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...